Therefore, while the inhibition of p38 signaling may manifest anti-inflammatory effects, it is crucial to consider the potential ramifications on other cell functions and the delicate equilibrium between inflammation and tissue repair in the context of COPD. Here, MAPK1 is linked to chronic obstructive pulmonary disease.